CrossrefInfokarte
Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish · 2018
DOI: 10.1177/2284240318784289 ↗Abstract
Kein Abstract verfügbar.
EUVIMED